Avarieux
back to explore
Ligand Pharmaceuticals Inc logo

LGND

Ligand Pharmaceuticals Inc
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 1992-11-18
$286.92
+2.65 (+0.93%)
last quote
Want the full multi-source brief on LGND?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
open in agent
Today
Open
$286.92
High
$290.33
Low
$281.69
Previous close
$284.27
Fundamentals
Market cap
$5.85B
P/E (TTM)
38.07x
P/S (TTM)
21.30x
P/B
3.66x
Gross margin
95.27%
Operating margin
34.46%
Net margin
55.95%
Rev growth (YoY)
51.24%
EPS growth (YoY)
—
ROE
16.19%
52W high
$326.63
52W low
$161.82
Beta
1.23x
Industry peers
by market cap
BLTE+2.53%LQDA+4.14%AMRX+2.15%DFTX+1.04%EWTX-0.64%AMLX+2.01%ELVN+1.99%INDV+1.42%
Upcoming earnings
next 30 days
2026-11-04in 61 days
Q3 2026EPS est $2.41Rev est $80.5M
Recent SEC filings
CIK 886163filing-language history →
8-K/A2026-09-02reports 2026-07-14
1,460 KB
42026-08-14reports 2026-08-12
24 KB
42026-08-14reports 2026-08-12
9 KB
SCHEDULE 13G2026-08-13
13 KB
1442026-08-12
5 KB
1442026-08-12
6 KB
Recent news
2026-08-27 → 2026-09-03
Benzinga · 15h
If You Invested $100 In Ligand Pharmaceuticals Stock 5 Years Ago, You Would Have This Much Today
Ligand Pharmaceuticals (NASDAQ:LGND) has outperformed the market over the past 5 years by 17.28% on an annualized basis producing an average annual return of 28.4%. Currently, Ligand Pharmaceuticals has a market
SEC EDGAR Yahoo Finance TradingView Company website
This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial